Free radical generation and DNA damage induction by anthracyclines

The phrase "Free radical generation/DNA damage induction by anthracyclines" does not refer to a single molecule or receptor but rather describes key **mechanisms of action** for the class of anticancer drugs known as **anthracyclines**. These agents—including doxorubicin, daunorubicin, epirubicin, and idarubicin—exert their cytotoxic effects primarily through two interrelated processes: 1. **DNA Damage:** Anthracyclines intercalate into DNA and inhibit topoisomerase II activity ("poisoning" the enzyme), resulting in persistent double-stranded breaks that trigger cell cycle arrest and apoptosis in rapidly dividing cells[1][2][4]. 2. **Free Radical Generation:** Through redox cycling involving their quinone moiety, anthracyclines generate reactive oxygen species (ROS). This oxidative stress damages nuclear and mitochondrial DNA as well as other cellular structures; while it contributes to antitumor efficacy, it also underlies dose-limiting toxicities such as cardiomyopathy because cardiac tissue has low antioxidant capacity[1]. Additional research highlights that some analogs can separate chromatin-damaging activity from direct double-strand break formation—potentially reducing side effects while retaining anticancer potency[3]. The most relevant molecular target for classic anthracycline action is topoisomerase IIα; however, "free radical generation/DNA damage induction" itself is not a discrete druggable entity but rather an outcome/mechanism resulting from drug interaction with multiple cellular targets. Because this entry refers broadly to mechanisms rather than specific molecules or receptors—and thus cannot be considered a canonical therapeutic target—the field would benefit from mapping this concept instead onto its primary molecular mediator(s), especially topoisomerase IIα. If you need structured information on actual protein targets involved in these processes—such as "Topoisomerase II alpha"—please specify further so I can provide precise details on those entities.

Other names

Anthracycline-induced free radical generationAnthracycline-mediated DNA damageROS generation by anthracyclinesTopoisomerase II poisoning by anthracyclines

Drugs acting via this mechanism typically work through one or more of the following actions[1][2][4]: 1. Inhibition/poisoning of topoisomerase II, leading to double-stranded DNA breaks. 2. Intercalation into DNA, disrupting replication and transcription. 3. Generation of reactive oxygen species (ROS), causing oxidative damage to cellular components including nuclear and mitochondrial DNA. 4. Induction of chromatin/histone modifications.